Embed Size (px)
Citation preview
02. April 2020Eva Podgoršek & Anja ZimmermannCustomer Consultants Research Platforms
Scopus Bootcamp WebinarWie suche ich nach COVID-19 Informationen und welche zusätzlichen Quellen stehen mir zur Verfügung?How to find information on COVID-19 and which additional resources to access?
Agenda• Working from home: Your options for remote access
• Which information on COVID-19 does Elsevier provide?− Coronavirus Information Center− Research publications and books content on ScienceDirect− Feeding content into repositories of health organisations− Author (& Editor) Resilience Center− Impact on the journal submission process
• How to search for COVID-19 related content on Scopus? (Live Demo)
• Questions & Answers
Working from home: Your options for remote access
How to request remoteaccess:
Your users can access your library’s Elsevier subscriptions anytime and anywhere, without being limited to your IP address range.
With remote access activated, your users will have every chance to connect with the content they need for their research.
All you need to do is fill out this short form to get started.
https://service.elsevier.com/app/answers/detail/a_id/28166/supporthub/elsevieraccess/
Different options for remote access
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
We are actively working with our customers to support expanded Remote Access to subscribed content given campus and workplace closures.
Options for setting up Remote Access to ScienceDirect:• Set up remote access using your institutional email address – if your institution has this
enabled, then you will be prompted to create a personal account which you can use to access ScienceDirect/ Scopus from anywhere
• Log in with your institutional credentials – if your institution has this enabled, you will be able to login via your institution and then access ScienceDirect/ Scopus from anywhere
• If neither of these options work, you can also attempt to connect via your institution e.g. by VPN or proxy server access if your institution provides such services.
Go to the Elsevier Support Center for more information
Setting up remote access through federated access (Shibboleth/ Open Athens etc.)
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
Where to start if your institution does not yet have federated access:• You need to have software that supports Security Assertion
Markup Language (SAML) 2.0 and has access to your users' directory, and you must join a federation in your country (Germany - DFN; Austria - ACOnet; Switzerland - SWITCHaai).
• Your IdP metadata must be loaded to your federation and our systems will automatically consume it within 24 hours. When you're ready, you can contact your Elsevier representative or Elsevier support and request for it to be enabled.
• If you don't have your own software, you can look into subscribing to OpenAthens - this is the only paid service that provides federated access to clients that is fully integrated with Elsevier.
For further information (or if you're a corporate institution), please go here.
Setting up remote access through federated access (Shibboleth/ Open Athens etc.)
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
Once you tell us your institution, we will ask you to sign in via that institution:
Once at your identity provider, you will be asked to sign in. Please note this is an example only and each identity provider will look different:
Setting up remote access via E-Mail domain confirmation
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
If your institution is not part of a Shibboleth/ Open Athens federation that we support, you can request remote access via e-mail domain confirmation. This allowsusers to set up individual Elsevier accounts domain and confirm their institutional access by clicking a link in an email sent to their institutional email box.
Setting up remote access via E-Mail domain confirmation
This remote access option allows you to sign in and prove your institutional association via an email sent to your institutional mailbox.
Once you tell us your institution, and corresponding institutional email, we will send you an email:
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
Setting up remote access via E-Mail domain confirmation
Click the link in the email you receive:
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
Once you click the link, you'll see a page that offers you the option of continuing anonymously. Clicking that option means you'll be returned to the product that you were using with a proven institutional connection.
Setting up remote access for Science Direct via Google CASA
https://service.elsevier.com/app/answers/detail/a_id/29795/supporthub/sciencedirect/
Google CASAAdditionally, to further support library users’ access to ScienceDirect content remotely, we have implemented Campus-Activated Subscriber Access (CASA) for all institutions participating in Google Scholar’s Subscriber Links program.
CASA is the remote access extension of Google Scholar’s Subscriber Links program. It provides off-campus users with one-click access to their institutional subscriptions directly from Google Scholar search results.
CASA is automatically enabled for institutions participating in the Google Scholar Subscriber Links program. If your institution already takes part in Subscriber Links, then no further action is needed on your part to benefit from CASA. If you would like to participate in Subscriber Links and CASA, please inform your Account Manager.
Setting up remote access with institutional instructions
https://service.elsevier.com/app/answers/detail/a_id/28208/supporthub/elsevieraccess/p/15095/
This option enables us to display a customized message giving users instructions on how to obtain remote access via their institution. It can be used, for example, to include a link to the institutions proxy server portal or provide instructions for signing in via VPN.
Which information on COVID-19 does Elsevier provide?
Coronavirus Information Center
https://www.elsevier.com/connect/coronavirus-information-center
• All resources in the Information Center are free to access, in total over 20.000 publications
Researchers• Content includes early-stage and peer-reviewed research
on COVID-19 from journals, including The Lancet and CellPress, as well as 20K related articles
• Machine-readable data for TDM
Clinicians• Evidence-based skill guides and care plans for treatment,
safety and patient education, as well as emergencywebinars by the Centers for Disease Control and Prevention (CDC)
Patients• 3D4Medical coronavirus video, resources from the CDC
and WHO, and information about Elsevier's Patient Access Program for research
https://www.sciencedirect.com/quicksearches/coronavirus
https://www.sciencedirect.com/quicksearches/coronavirus
Recent book publications on Corona:Next to journal publications the available content on ScienceDirect also includes book chapters of Corona-related titles:
• Novel Coronavirus from Wuhan China, 2019-20
• Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)
• Viral Infections• Coronaviruses
Supporting students & educators:In addition, over 257 English languagetextbooks have been made available for 90 days for institutions who already have book orjournal subscriptions to support students whohave difficulties accessing print copies of theircourse-required textbooks and assist teachingstaff in continuing their courses digitally.
For a list linking the respective titles, pleaseclick here.
Should there be an urgent need for access toinformation in a certain ScienceDirect eBooks-field, please contact us and we are open toworking out a practical solution with you, e.g. via free trial access.
Corona-related books content on ScienceDirect
Further resource hubs for research & drugdiscovery
https://www.elsevier.com/connect/coronavirus-information-center
COVID-19 Resource Center
Coronavirus Resource Hub
Coronavirus Research Repository
On the Elsevier Coronavirus Information Center, you will also find links to resources directly provided by The Lancet, Cell Press and other publishers:
SARS-CoV-2 and COVID-19
Coronavirus: Latest news & resources
Coronavirus Resources & News
Novel Coronavirus Resources
Coronavirus
https://wellcome.ac.uk/press-release/publishers-make-coronavirus-covid-19-content-freely-available-and-reusable
Making publications & data available in public health repositories• Elsevier is making all its research and data content on its
COVID-19 Information Center available to PubMed Central, the archive of biomedical and life science at the US National Institutes of Health’s National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
• Elsevier (and other publishers) signed the Wellcome Trust Statement comitting to share relevant research and data on nCoV rapidly and openly
• This also includes: making all COVID-19 and coronavirus-related publications, and the available data supporting them, immediately accessible in PubMed Central (PMC) and license it in ways that facilitate reuse• The additional access allows researchers to use
artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.
https://wellcome.ac.uk/press-release/publishers-make-coronavirus-covid-19-content-freely-available-and-reusable
Making publications & data available in public health repositories• Elsevier is making all its research and data content on its
COVID-19 Information Center available to PubMed Central, the archive of biomedical and life science at the US National Institutes of Health’s National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
• Elsevier (and other publishers) signed the Wellcome Trust Statement comitting to share relevant research and data on nCoV rapidly and openly
• This also includes: making all COVID-19 and coronavirus-related publications, and the available data supporting them, immediately accessible in PubMed Central (PMC) and license it in ways that facilitate reuse• The additional access allows researchers to use
artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.
https://www.elsevier.com/authors/journal-authors/misc/author-resource-center
Supporting authors (& editors):
• Collection of some of the main tools, systems and other resources that might be of use to authors
• Aims to assist our authors with continuing their regular publishing activities as far as possible
• Content is regularly added
• A similar resource centerhas been created for our editors(and will possibly be created for reviewers and librarians)
https://www.elsevier.com/editors/editor-resilience-center
We value our author and editor communities and will do our utmost to support them under theseunprecedented circumstances as they work aroundthe clock.
• Outreach from Elsevier Publishers is ongoing; but weencourage our authors and editors to reach out to theirElsevier contacts whenever needed.
• We have asked our (internal and external) editors todeposit relevant manuscripts to the WHO already at thestage of submission, cutting back on review time, and accelerating access to latest knowledge for researchers.
• Authors and reviewers will be provided with statusupdates regarding revision/ reviewer deadlines byJournal Managers and granted additional time. Journal homepages and submission sites have been equipped withinformation banners accordingly.
• Further mechanisms are in place to support the editorialprocess. Elsevier Publishers remain in close exchange witheditors and can discuss options for their respective journal.
Impact on the journal submission process
How to search for COVID-19 related content on Scopus?
Live Demo!
Scopus search strategies:
As a starting point, search in all fields of the document:
"COVID-19" OR Coronavirus OR "Corona virus" OR "2019-nCoV" OR "SARS-CoV" OR "MERS-CoV" OR “Severe Acute Respiratory Syndrome” OR “Middle East Respiratory Syndrome”
If you want to search more specifically, use your search in the title, abstract and the keywords of the document:
TITLE-ABS-KEY ("COVID-19" OR Coronavirus OR "Corona virus" OR "2019-nCoV" OR "SARS-CoV" OR "MERS-CoV" OR “Severe Acute Respiratory Syndrome” OR “Middle East Respiratory Syndrome”)
You can change/adjust/narrow your search. For example by using the AND operator:
(TITLE-ABS-KEY ("COVID-19" OR Coronavirus OR "Corona virus" OR "2019-nCoV" OR "SARS-CoV" OR "MERS-CoV" OR “Severe Acute Respiratory Syndrome” OR “Middle East Respiratory Syndrome”) AND TITLE-ABS-KEY (lopinavir OR ritonavir))
Scopus search strategies:
This is an example of a comprehensive search strategy:
TITLE-ABS-KEY(coronavirus OR {corona virus} OR coronovirus OR coronaviridae OR coronavirinae OR CORONAVİRÜSÜ OR alphacoronavirus OR {alpha-CoVs} OR {α-CoVs} OR betacoronavirus OR {beta-CoVs} OR {β-CoVs} OR deltacoronavirus OR {delta-CoVs} OR {δ-COV} OR gammacoronavirus OR {gamma-CoVs} OR {γ-COV} OR orthocoronavirinae OR pancoronavirusOR {SADS-CoV} OR {HCOV-EMC} OR {2019-nCoV} OR {2020-nCOV} OR {COVID} OR {COVID-19} OR {SeACoV} OR {SARS-CoV} OR {sars病毒} OR {严重急性呼吸综合征} OR "severe acute respiratory syndrome" OR {MERS-CoV} OR {MERS病毒} OR "Middle East respiratory syndrome" OR "Porcine epidemic diarrhea virus" OR "infectious bronchitis virus" OR (({HK11} OR {HK12} OR {HK13} OR {HKU20} OR {HKU19} OR {OC43} OR {NL63} OR {HKU1} OR {229E} OR {HK-11} OR {HK-12} OR {HK-13} OR {HKU-20} OR {HKU-19} OR {OC-43} OR {NL-63} OR {HKU-1} OR {229-E} OR {FeCV} OR {HuCoV} OR {nCoV} OR {ECoV} OR {PDCoV} OR {Pedv} OR {PhCoV} OR {BCoV} OR (({SARS} NOT {SARs OF}) NOT "Structure-activity relationships")) AND (virus OR {CoV} OR {病毒})))
Available Field codes
Scopus has an extensive list of field codes to refine your search.
To view the full list, please click the link below
https://service.elsevier.com/app/answers/detail/a_id/21730/supporthub/scopus/kw/Keywords
Keywords and indexed terms
A team of professional indexers manually adds index terms for 80% of the titles included in Scopus according to the following controlled vocabularies:
• Ei Thesaurus (engineering, technology, physical sciences)• Emtree medical terms (life sciences, health sciences)• MeSH (life sciences, health sciences)• GEOBASE Subject Index (geology, geography, earth and
environmental sciences)• FLX terms, WTA terms (fluid sciences, textile sciences)• Regional Index (geology, geography, earth and environmental
sciences)• Species Index (biology, life sciences)
https://service.elsevier.com/app/answers/detail/a_id/21730/supporthub/scopus/kw/Keywords
Overview of field codes & operators
• OR• W/n , PRE/n => Proximity (schizophrenia w/8 genome)• AND• AND NOT
Truncations:• Asterics * => develop* (finds: develop, developing, development)
*somatic (finds: somatic, physosomatic )• Questionmark ? => de?elop
Search for phases:• Double quotation marks “..“ “heart attack“ (finds: heart attack or heart-attack
or heart attacks)• Curly brackets {…} ( {heart-attack} finds only heart-attack ) Ctrl+Alt+7 and Ctrl+Alt+0
https://service.elsevier.com/app/answers/detail/a_id/11365/supporthub/scopus/kw/operators/
Your Contacts at Elsevier – We're here to support you!
Scopus/ ScienceDirectAnja ZimmermannConsultant Research Platformst: +49 172 810 39051@: [email protected]
Eva PodgoršekConsultant Research Platformst: +49 172 729 3363@: [email protected]
BooksTorsten GuniaSolution Sales Manager ScienceDirect eBookst: +31683039644@: [email protected]
Franziska PohleSolution Sales Manager ScienceDirect eBookst: +31682508927@: [email protected]
Anja Zimmermann Consultant Research Platforms
Academic & Government
Eva Podgoršek Consultant Research Platforms
Academic & Government
t: +49 172 810 39051 @: [email protected]
t: +49 172 729 3363@: [email protected]
Tanja Giessner Customer Marketing Manager DACH
t: +31 20 485 2366@: [email protected]
![Benefits Communication Bootcamp [Webinar Version]](https://img.pdfslide.net/doc/110x75/549e93f1b4795960208b478c/benefits-communication-bootcamp-webinar-version.jpg)
